FGF23 and viral infectious disease: Currently, most studies evaluating the association between plasma FGF23 levels and infectious morbidity were performed before the SARS-CoV-2 pandemic and evaluated other infection-related hospitalizations caused by severe bacterial and viral infections [16,17].